SecBot SecBot
13FINSTITUTION · CIK 0001263508 · 2026-Q2 · Filed Aug 14, 2026

Baker Bros. Advisors

BAKER BROS. ADVISORS LP
$20.0B
13F long value · 2026-Q2
Positions84
CategoryAsset manager
Quarters tracked9
●#317 of 556 by 13F long value
Size rank 5/10
7NEW2ADD32×+3TRIM8EXIT
Snapshot
Baker Bros. Advisors's 13F portfolio at a glance: size, concentration and this quarter's activity.
13F long value
$20.0B
Positions
84 (1 unmapped)
Top 84 long weight
99.9%
Quarters tracked
9
Latest 13F filed
Aug 14, 2026
New positions
7
Exits / near-exits
8
13F long value by quarter
Reported long equity value each quarter: fund flows plus market moves. Option notional is not included.
$7.8B
2024-Q2
$9.6B
2024-Q3
$9.4B
2024-Q4
$9.0B
2025-Q1
$10.3B
2025-Q2
$13.8B
2025-Q3
$17.1B
2025-Q4
$17.4B
2026-Q1
$20.0B
2026-Q2
Top holdings · 2026-Q2
The fund's largest reported positions. The long positions shown cover 99.9% of the long value.
TickerIssuerWeightValueSharesSince 2026-Q2
INCY INCYTE CORPINCYTE CORP17.5%$3.5B30.8M+6.1%
ONC BeOne Medicines Ltd.BeOne Medicines Ltd.12.6%$2.5B8.8M+44.3%
RVMD Revolution Medicines, Inc.Revolution Medicines, Inc.10.7%$2.1B11.4M-10.9%
MDGL MADRIGAL PHARMACEUTICALS, INC.MADRIGAL PHARMACEUTICALS, INC.5.8%$1.2B2.1M-21.0%
ACAD ACADIA PHARMACEUTICALS INCACADIA PHARMACEUTICALS INC5.4%$1.1B42.9M-26.2%
KYMR Kymera Therapeutics, Inc.Kymera Therapeutics, Inc.5.0%$992.7M8.7M+9.7%
INSM INSMED IncINSMED Inc4.7%$937.8M8.8M+15.3%
CELC Celcuity Inc.Celcuity Inc.4.2%$828.2M7.9M-42.1%
KOD Kodiak Sciences Inc.Kodiak Sciences Inc.3.9%$776.1M19.9M+158.5%
RYTM RHYTHM PHARMACEUTICALS, INC.RHYTHM PHARMACEUTICALS, INC.3.1%$622.3M5.6M-3.2%
PRAX Praxis Precision Medicines, Inc.Praxis Precision Medicines, Inc.2.9%$587.0M1.8M-7.3%
ALKS Alkermes plc.Alkermes plc.2.6%$524.6M10.0M-11.2%
SMMT Summit Therapeutics Inc.Summit Therapeutics Inc.2.4%$477.7M32.8M-18.9%
GRAL GRAIL, Inc.GRAIL, Inc.1.4%$275.0M4.0M+54.7%
ABCL AbCellera Biologics Inc.AbCellera Biologics Inc.1.3%$259.1M33.0M+41.7%
Quarterly changes · 2026-Q2
What Baker Bros. Advisors opened, added, trimmed and exited this quarter, largest dollar moves first.
ActionTickerIssuerPrev sharesCurr sharesChangeValue Δ
EXITABVX EXIT Abivax S.A. Abivax S.A.875.8K0-100.0%-$97.5M
TRIMEWTX TRIM Edgewise Therapeutics, Inc. Edgewise Therapeutics, Inc.6.6M3.7M-43.7%-$56.7M
ADDIDYA ADD IDEAYA Biosciences, Inc. IDEAYA Biosciences, Inc.3.9M5.0M+26.9%+$55.2M
EXITSYRE EXIT Spyre Therapeutics, Inc. Spyre Therapeutics, Inc.1.0M0-100.0%-$50.4M
2×+RLAY 2×+ Relay Therapeutics, Inc. Relay Therapeutics, Inc.1.2M2.8M+143.7%+$41.3M
NEWFTH NEW Faeth Therapeutics, Inc. Faeth Therapeutics, Inc.01.3MNew+$32.2M
EXITCNTA EXIT Centessa Pharmaceuticals plc Centessa Pharmaceuticals plc670.8K0-100.0%-$26.6M
ADDCLDX ADD Celldex Therapeutics, Inc. Celldex Therapeutics, Inc.665.4K1.2M+77.7%+$22.9M
EXITIMCR EXIT Immunocore Holdings plc Immunocore Holdings plc734.4K0-100.0%-$22.1M
EXITCTNM EXIT Contineum Therapeutics, Inc. Contineum Therapeutics, Inc.1.4M0-100.0%-$18.6M
Conviction over time
Portfolio weight of the current top long holdings, quarter by quarter; rising weight = growing conviction.
INCY 17.5%
ONC 12.6%
RVMD 10.7%
MDGL 5.8%
ACAD 5.4%
KYMR 5.0%
INSM 4.7%
CELC 4.2%
KOD 3.9%
RYTM 3.1%